Back
bluebird bio Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
24
BLUE
bluebird bio
Last Price:
0.41
Seasonality Move:
6.96%
Buy
68
VRTX
Vertex Pharmaceuticals
Last Price:
516.82
Seasonality Move:
6.39%
Sell
24
bluebird bio (BLUE)
is a Sell
Is bluebird bio a Buy, Sell or Hold?
- The current bluebird bio [BLUE] share price is $0.41. The Score for BLUE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- BLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $516.74. The Score for VRTX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BLUE Stock Price Chart
What is bluebird bio's stock price today?
-
The bluebird bio share price today is $0.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLUE is experiencing slight buying pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $516.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 32.91 | Sell |
| Chaikin Money Flow: | 1891067 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 0.52) | Sell |
| Bollinger Bands (100): | (0.47 - 1.01) | Sell |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.32 | Buy |
| Relative Strength Index (14 RSI): | 69.1 | Buy |
| Chaikin Money Flow: | 707634 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (463.95 - 492.55) | Buy |
| Bollinger Bands (100): | (466.25 - 490.85) | Buy |
BLUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.45 | Sell |
| 20-day SMA: | 0.48 | Sell |
| 50-day SMA: | 0.51 | Sell |
| 200-day SMA: | 0.93 | Sell |
| 8-day EMA: | 0.44 | Sell |
| 20-day EMA: | 0.47 | Sell |
| 50-day EMA: | 0.55 | Sell |
| 200-day EMA: | 1.14 | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 488.53 | Buy |
| 20-day SMA: | 482.44 | Buy |
| 50-day SMA: | 475.32 | Buy |
| 200-day SMA: | 451.94 | Buy |
| 8-day EMA: | 493.73 | Buy |
| 20-day EMA: | 483.69 | Buy |
| 50-day EMA: | 477.92 | Buy |
| 200-day EMA: | 450.84 | Buy |
bluebird bio Earnings Growth & BLUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.46 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.57 per share, and an increase next year of $18.26 per share.
bluebird bio Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||